|
1
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar
|
|
2
|
Liu T, Ye L, He Y, Chen X, Peng J, Zhang
X, Yi H, Peng F and Leng A: Combination gene therapy using
VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric
carcinoma growth. Exp Mol Pathol. 91:745–752. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee SW, Lee YL, Lee YJ, Park SY, Kim IS,
Choi TH, Ha JH, Ahn BC and Lee J: Enhanced antitumor effects by
combination gene therapy using MDR1 gene shRNA and HSV1-tk in a
xenograft mouse model. Cancer Lett. 291:83–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su GQ, Su G and Huang ZH:
Adenovirus-mediated tissue-targeted expression of the CDglyTk gene
for the treatment of breast cancer. Mol Med Rep. 6:321–329.
2012.PubMed/NCBI
|
|
5
|
Jia W, Mei L, Wang Y, Liu L and Che G:
Double suicide genes selectively kill human umbilical vein
endothelial cells. Virol J. 8:742011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Niu HX, Du T, Xu ZF, Zhang XK and Wang RG:
Role of wild type p53 and double suicide genes in interventional
therapy of liver cancer in rabbits. Acta Cir Bras. 27:522–528.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Foekens JA, Peters HA, Grebenchtchikov N,
Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH,
Sweep CG and Klijn JG: High tumor levels of vascular endothelial
growth factor predict poor response to systemic therapy in advanced
breast cancer. Cancer Res. 61:5407–5414. 2001.PubMed/NCBI
|
|
8
|
Konecny GE, Meng YG, Untch M, Wang HJ,
Bauerfeind I, Epstein M, Stieber P, Vernes JM, Gutierrez J, Hong K,
Beryt M, Hepp H, Slamon DJ and Pegram MD: Association between
HER-2/neu and vascular endothelial growth factor expression
predicts clinical outcome in primary breast cancer patients. Clin
Cancer Res. 10:1706–1716. 2004. View Article : Google Scholar
|
|
9
|
Linderholm B, Grankvist K, Wilking N,
Johansson M, Tavelin B and Henriksson R: Correlation of vascular
endothelial growth factor content with recurrences, survival, and
first relapse site in primary node-positive breast carcinoma after
adjuvant treatment. J Clin Oncol. 18:1423–1431. 2000.
|
|
10
|
Nagaiah K, Venkatesham A, Srinivasa Rao R,
Saddanapu V, Yadav JS, Basha SJ, Sarma AV, Sridhar B and Addlagatta
A: Synthesis of new cis-fused tetrahydrochromeno [4,3-b] quinolines
and their antiproliferative activity studies against MDA-MB-231 and
MCF-7 breast cancer cell lines. Bioorg Med Chem Lett. 20:3259–3264.
2010.PubMed/NCBI
|
|
11
|
Kim JE, Chung WY, Chun KS, Lee CK, Park
HJ, Kim WB and Park KK: Pleurospermum kamtschaticum extract
induces apoptosis via mitochondrial pathway and NAG-1 expression in
colon cancer cells. Biosci Biotechnol Biochem. 74:788–792. 2010.
View Article : Google Scholar
|
|
12
|
Mizrak A, Bolukbasi MF, Ozdener GB,
Brenner GJ, Madlener S, Erkan EP, Ströbel T, Breakefield XO and
Saydam O: Genetically engineered microvesicles carrying suicide
mRNA/protein inhibit schwannoma tumor growth. Mol Ther. 21:101–108.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi BR, Choi KJ, Kim SU and Choi KC:
Therapeutic potential of stem cells expressing suicide genes that
selectively target human breast cancer cells: Evidence that they
exert tumoricidal effects via tumor tropism (Review). Int J Oncol.
41:798–804. 2012.
|
|
14
|
Hong S, Zhang P, Zhang H, Jia L, Qu X,
Yang Q, Rong F and Kong B: Enforced effect of tk-MCP-1 fusion gene
in ovarian cancer. J Exp Clin Cancer Res. 31:742012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cramer F, Christensen CL, Poulsen TT,
Badding MA, Dean DA and Poulsen HS: Insertion of a nuclear factor
kappa B DNA nuclear-targeting sequence potentiates suicide gene
therapy efficacy in lung cancer cell lines. Cancer Gene Ther.
19:675–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo XR, Li JS, Niu Y and Miao L:
Adenovirus-mediated double suicide gene selectively kills gastric
cancer cells. Asian Pac J Cancer Prev. 13:781–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zarogoulidis P, Chatzaki E,
Hohenforst-Schmidt W, Goldberg EP, Galaktidou G, Kontakiotis T,
Karamanos N and Zarogoulidis K: Management of malignant pleural
effusion by suicide gene therapy in advanced stage lung cancer: a
case series and literature review. Cancer Gene Ther. 19:593–600.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang N, Dong X, Sun Y, Cai X, Zheng C, He
A, Xu K and Zheng X: Cytotoxic effects of adenovirus- and
lentivirus-mediated expression of Drosophila melanogaster
deoxyribonucleoside kinase on Bcap37 breast cancer cells. Oncol
Rep. 29:960–966. 2013.PubMed/NCBI
|
|
19
|
Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung
EB, Kim SU and Choi KC: Human amniotic fluid-derived stem cells
expressing cytosine deaminase and thymidine kinase inhibits the
growth of breast cancer cells in cellular and xenograft mouse
models. Cancer Gene Ther. 19:412–419. 2012. View Article : Google Scholar
|
|
20
|
Li XH, Zhou P, Wang LH, Tian SM, Qian Y,
Chen LR and Zhang P: The targeted gene (KDRP-CD/TK) therapy of
breast cancer mediated by SonoVue and ultrasound irradiation in
vitro. Ultrasonics. 52:186–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joo KM, Park IH, Shin JY, Jin J, Kang BG,
Kim MH, Lee SJ, Jo MY, Kim SU and Nam DH: Human neural stem cells
can target and deliver therapeutic genes to breast cancer brain
metastases. Mol Ther. 17:570–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koshikawa N, Takenaga K, Tagawa M and
Sakiyama S: Therapeutic efficacy of the suicide gene driven by the
promoter of vascular endothelial growth factor gene against hypoxic
tumor cells. Cancer Res. 60:2936–2941. 2000.PubMed/NCBI
|
|
23
|
Radovich M, Hancock BA, Kassem N, Mi D,
Skaar TC and Schneider BP: Resequencing of the vascular endothelial
growth factor promoter reveals haplotype structure and functional
diversity. Angiogenesis. 13:211–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boucher PD, Im MM, Freytag SO and Shewach
DS: A novel mechanism of synergistic cytotoxicity with
5-fluorocytosine and ganciclovir in double suicide gene therapy.
Cancer Res. 66:3230–3237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song NM, Jun S, Zang DY, Kim SG, Park HR
and Kang D: Differential susceptibility of gastric cancer cells to
TRAIL-induced apoptosis. Oncol Rep. 29:1224–1230. 2013.PubMed/NCBI
|
|
26
|
Wang T, D’Souza GG, Bedi D, Fagbohun OA,
Potturi LP, Papahadjopoulos-Sternberg B, Petrenko VA and Torchilin
VP: Enhanced binding and killing of target tumor cells by
drug-loaded liposomes modified with tumor-specific phage fusion
coat protein. Nanomedicine. 5:563–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Terakawa M, Tsuda H, Ashida H and Sato S:
Assessment of tissue alteration in skin after interaction with
photomechanical waves used for gene transfection. Lasers Surg Med.
42:400–407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mandoky L, Szende B, Géczi L, Bodrogi I,
Kásler M and Bak M: Apoptosis regulation and spontaneous apoptosis
index of testicular germ cell tumors are associated with
differentiation and resistance to systemic treatment. Anticancer
Res. 28:1641–1649. 2008.PubMed/NCBI
|
|
29
|
Ortiz R, Prados J, Melguizo C, Rama AR,
Alvarez PJ, Rodríguez-Serrano F, Caba O, Boulaiz H and Aranega A:
Gef gene therapy enhances the therapeutic efficacy of cytotoxics in
colon cancer cells. Biomed Pharmacother. 66:563–567. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang W, He Y, Zhou S, Ma Y and Liu G: A
novel Bifidobacterium infantis-mediated TK/GCV suicide gene
therapy system exhibits antitumor activity in a rat model of
bladder cancer. J Exp Clin Cancer Res. 28:1552009.
|
|
31
|
Zhang Z, Lin J, Chu J, Ma Y, Zeng S and
Luo Q: Activation of caspase-3 noninvolved in the bystander effect
of the herpes simplex virus thymidine kinase gene/ganciclovir
(HSV-tk/GCV) system. J Biomed Opt. 13:0312092008. View Article : Google Scholar : PubMed/NCBI
|
